Navigation Links
NeoStem Announces Proposed Public Offering of Common Stock
Date:7/18/2011

tus supplement relating to the offering with the SEC, which will be available along with the prospectus filed with the SEC in connection with the shelf registration, on the SEC's website at www.sec.gov.

About NeoStem, Inc.NeoStem, Inc. ("NeoStem") is engaged in the development and manufacturing of cell-based therapies in the U.S. and globally. Its January, 2011 acquisition of Progenitor Cell Therapy ("PCT"), and its July 14, 2011 announcement of the signing of a merger agreement to acquire Amorcyte, Inc. ("Amorcyte"), position NeoStem to achieve its mission of capturing the paradigm shift to cell therapy.

PCT gives NeoStem not only access to a world class contract manufacturing cell therapy company but provides NeoStem a platform and expertise around the evaluation, development and regulatory requirements to develop autologous, allogeneic, immunomodulatory and vaccine-based therapeutics.

NeoStem also holds the worldwide exclusive license to VSEL(TM) Technology, which uses very small embryonic-like stem cells, shown to have several physical characteristics that are generally found in embryonic stem cells, and is pursuing the licensing of other technologies for therapeutic use. NeoStem owns 80% of Athelos Corporation, a company developing a T-cell therapeutic with potential in a range of auto-immune conditions such as graft versus host disease, asthma and diabetes. NeoStem's acquisition of Amorcyte, once the transaction is completed, will give the Company a Phase 2 asset for the treatment of Acute Myocardial Infarctions and a Phase 1 asset for Congestive Heart Failure. NeoStem will own 100% of the worldwide rights to the Amorcyte programs.

Furthermore, NeoStem is building its Chinese presence by establishing an operations lab for cell-based manufacturing in Beijing, as well as commercializing cellular therapies in China through the establishment of relationships with a network of hospitals.


'/>"/>

SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeoStem Signs Definitive Merger Agreement to Acquire Amorcyte in Equity Transaction
2. NeoStem Announces Agreement with Nankai Hospital in Tianjin to Offer NeoStems Licensed Orthopedic Technology
3. NeoStems Suzhou Erye Pharmaceutical Receives Two Awards at the Chempharm Brand Summit 2011
4. NeoStems Subsidiary Progenitor Cell Therapy Receives FACT Accreditation for Its New Allendale, New Jersey Manufacturing Facility
5. NeoStem to Present at 10th Annual Needham Healthcare Conference on Tuesday, April 5
6. NeoStem Provides Results for 2010 and an Update on Recent Activities
7. NeoStem To Present at Rodman & Renshaw Annual China Investment Conference on Tuesday, March 8
8. NeoStem to Launch New Service and Has Engaged Healthcare Personality Dr. Manny Alvarez to Serve as Spokesperson
9. NeoStem to Present at 13th Annual BIO CEO & Investor Conference
10. $1,700,000 Funding of NeoStems Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Research Program
11. NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 Dans ... santé, le ferroviaire ou encore l,énergie, les ... progressivement accès à leurs données. Ces données ... installés au cœur des voitures, trains, avions, ... de milliards le nombre de machines connectées ...
(Date:9/23/2014)... , Sept. 23, 2014  Decision Resources ... reimbursement (P&R) decision criteria and payer requirements ... insights into each country, allow pharma to ... markets.  Global market access is extremely complex, ... access requirements and challenges—and a vast variety ...
(Date:9/23/2014)... ORLANDO, Fla. and DUBLIN ... Inc. (OTC-BB: TNIB) ("we" or the "Company"), a ... innovative therapies for autoimmune diseases in emerging nations, ... has approved our common stock for DTC,s Deposit ... Fast Automated Securities Transfer Service ("FAST") transfer agent ...
Breaking Medicine Technology:Altran transforme le big data du monde industriel en nouveau business 2Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 2Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 3Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 4TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4
... , WASHINGTON, Jan. 11 ... Baseball star Aaron Boone is featured in January on , Sharing ... that tells the compelling and inspirational stories of real patients. , Sharing ... is sponsored by the Pharmaceutical Research and Manufacturers of America ...
... , , SAN JOSE, Calif., Jan. ... and control solutions for life sciences process applications, announced ... TruFluor sensors for dissolved oxygen or pH and process ... family is optimized for accuracy, lifetime, and ease of ...
Cached Medicine Technology:Major League Baseball Star Aaron Boone on 'Sharing Miracles' 2Major League Baseball Star Aaron Boone on 'Sharing Miracles' 3Single-Use Sensor Product Family Enters High Volume Production 2
(Date:9/23/2014)... Dennis Thompson HealthDay Reporter ... Coupled with worldwide marches demanding action on climate change, ... weather patterns in the United States may soon exacerbate ... and other heat-related illnesses are expected to increase as ... author Dr. Jonathan Patz, director of the Global Health ...
(Date:9/23/2014)... at Cincinnati Children,s Hospital Medical Center have published ... (EG). The study, published in The Journal ... EG is a systemic disorder that has high ... tract, involves a series of allergy-associated-immune mechanisms and ... distinct from that of a related disorder, eosinophilic ...
(Date:9/23/2014)... a potential source of student diversity for medical ... however, there are significant challenges to enhancing the ... medical schools. The authors recommend that medical school ... be more inclusive of community college students. , ... Francisco and San Jose City College found that, ...
(Date:9/23/2014)... shows that adolescents who suffer from sleep disturbance or ... academically compared to those who enjoy a good night,s ... journal Sleep Medicine . , In a new ... and 19 from Uppsala County, researchers from Uppsala University ... sleep duration (less than 7 hours per day) increased ...
(Date:9/23/2014)... PA (PRWEB) September 23, 2014 If ... ongoing dialysis, dressing for the treatment may be a ... a type of garment that is designed to improve ... patients to receive dialysis without having to remove, tear ... while insuring privacy and preserving their dignity. At the ...
Breaking Medicine News(10 mins):Health News:Health Woes to Worsen Due to Climate Change, Study Warns 2Health News:Health Woes to Worsen Due to Climate Change, Study Warns 3Health News:Advancing the understanding of an understudied food allergy disorder 2Health News:Advancing the understanding of an understudied food allergy disorder 3Health News:Medical students who attended community college likelier to serve poor communities 2Health News:Apparel for Dialysis Patients Invented by InventHelp Client (CBA-2492) 2
... a quarter million deaths in the United States annually, ... as prescribed . A Mayo Clinic research team has ... medications. The tool is clearly effective and preferred by ... in the May 28 issue of the Archives of ...
... increase levels of high-density lipoprotein, or 'good,' ... issue of Archives of Internal Medicine. ... is an independent risk factor for cardiovascular disease, ... background information in the article. There is strong ...
... better predict the likelihood of full or partial recovery ... according to a study published in the June issue ... that the possibility and extent of neurological recovery after ... by rigorous assessment of MR images," said co-author Michael ...
... Asia - including India's - met European Union members in ... crises. ,The two-day Asia-Europe Meeting (ASEM) of 43 ... seeking deep cuts in world carbon-dioxide emissions and Asian governments ... held every two years. India, Pakistan and Mongolia are attending ...
... multidetector computed tomography (MDCT) can aid forensics teams in ... study published in the June issue of Radiology . ... demonstrating airway froth and sediment that are indicative of ... be used either to facilitate or reduce the need ...
... genes may actually contribute to learning the supposed "tonal languages", ... of Edinburgh University, UK, have exposed the first obvious connection ... in tonal languages can fundamentally alter the meaning of words, ... are so tough to learn for speakers of non-tonal languages ...
Cached Medicine News:Health News:Simple Tool Developed for Diabetics to Improve Compliance With Medications 2Health News:Simple Tool Developed for Diabetics to Improve Compliance With Medications 3Health News:Regular Exercise may Slightly Increase HDL Levels 2Health News:Recovery from Spinal Cord Injury can Be Predicted Using MRI 2Health News:EU Pushes Asian Nations on Climate Change Goals 2Health News:Death Due to Drowning can Be Identified With the Aid of 'Virtual Autopsy' 2Health News:Genes may Have a Role in Learning "tonal Languages" 2
... When your eyes feel dry, scratchy, or ... going to last. REFRESH PLUS® lubricant eye ... symptoms could be what youre looking for. ... the moisture eyes crave with a special ...
Due to its thick formula, REFRESH CELLUVISC Lubricant Eye Drops is ideal for persistent dry eye conditions. REFRESH CELLUVISC provides lasting relief and protection for dry, scratchy eyes....
...
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
Medicine Products: